MedTrace Logo

Validation of the REPS Prediction Tool

NCT03585400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101510

Last updated 2021-01-26

No results posted yet for this study

Summary

Neuromuscular blocking agents' (NMBA) use during surgery is associated with postoperative respiratory complications and increased risk of readmission to the hospital following ambulatory surgery. Residual neuromuscular block (rNMB) after surgery is difficult to identify. We have recently developed the REsidual neuromuscular block Prediction Score (REPS), that predicts the risk for postoperative rNMB. Our primary objective is now to assess the predictive ability of the REPS for respiratory complications within seven days following general anaesthesia. The secondary objective is to compare the predictive values of REPS and train-of-four (TOF)-ratio below 0.90 for respiratory complications.

Conditions

  • Residual Neuromuscular Blockade
  • Curarization, Postoperative Residual
  • Postoperative Respiratory Complication

Interventions

OTHER

Observational Study

Observational Study: Not Applicable for Observational Studies

Sponsors & Collaborators

Principal Investigators

  • Matthias Eikermann, MD, PhD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2019-12-10
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03585400 on ClinicalTrials.gov